Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-021955
Filing Date
2022-04-27
Accepted
2022-04-27 16:45:07
Documents
3
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea158784-def14a_lantern.htm DEF 14A 268851
2 GRAPHIC image_001.jpg GRAPHIC 112312
3 GRAPHIC image_002.jpg GRAPHIC 112299
  Complete submission text file 0001213900-22-021955.txt   579516
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39318 | Film No.: 22860482
SIC: 2834 Pharmaceutical Preparations